Hyun, Insoo https://orcid.org/0000-0001-6605-7112
Scharf-Deering, J. C. https://orcid.org/0000-0001-8924-3479
Sullivan, Sarah
Aach, John Dennis
Arlotta, Paola https://orcid.org/0000-0003-2184-2277
Baum, Matthew L. https://orcid.org/0000-0001-6840-8932
Church, George M. https://orcid.org/0000-0003-3535-2076
Goldenberg, Aaron
Greely, Henry T. https://orcid.org/0000-0002-1105-6734
Khoshakhlagh, Parastoo
Kohman, Richie E. https://orcid.org/0000-0002-7412-671X
Lopes, Melissa
Lowenthal, Caroline
Lu, Aric https://orcid.org/0000-0002-8276-8077
Ng, Alex H. M.
Pasca, Sergiu P. https://orcid.org/0000-0002-3216-3248
Paulsen, Bruna
Pigoni, Martina
Scott, Christopher T.
Silbersweig, David A.
Skylar-Scott, Mark A.
Truog, Robert D.
Lunshof, Jeantine E. https://orcid.org/0000-0002-5630-7947
Article History
First Online: 18 October 2022
Competing interests
: A.H.M.N. and P.K. are inventors on patents filed by the Presidents and Fellows of Harvard College and GC Therapeutics, Inc., and are co-founders of and have equity in GC Therapeutics, Inc. I.H. is a bioethics advisor for Bayer, the Novo Nordisk Foundation, and Rumi Therapeutics. P.A. is a member of the scientific advisory board at Herophilus, Rumi Therapeutics, and Foresite Labs, and is a co-founder of Vesalius. M.A.S.-S. and A.L. have submitted a patent application associated with engineered brain organoids (US Provisional Application Serial No. 63/048,502, filed July 6, 2020). Stanford University holds patents for the generation of cortical organoids/spheroids and assembloids (listing S.P.P. as an inventor). From September 1, 2021, M.P. has been an employee of Roche. G.M.C.’s competing interests are listed at . The remaining authors declare no competing interests.